Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2018 18:30 ET | Source: Immuron Limited

Immuron Reports Positive Results in NASH Clinical Trial

Headlines: First-In Class Anti-LPS Mechanism of Action confirmed for IMM-124EResults demonstrate excellent safety and tolerabilityStatistically significant reduction in serum endotoxin/...